Healthcare | March 14, 2026
Aster DM bags overwhelming shareholder backing for merger with Quality Care
The endorsement follows overwhelming support for the share swap preceding the merger,
The endorsement follows overwhelming support for the share swap preceding the merger,
Huwel’s diagnostic solutions leverage open RT-PCR system
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
Built on the Percept Platform and enhanced with BrainSense technology, the system can adjust stimulation levels in real time, responding to brain signals without manual intervention
The study will test the company’s lead product, ZI-MA4-1, in patients with advanced solid cancers
The approval is based on the SWIFT and ANCHOR phase III trials, which demonstrated sustained efficacy with a twice-yearly dosing regimen
If approved, Ameluz would become the first and only photodynamic therapy (PDT) photosensitizer for sBCC in the US
The FDA’s Center for Biologics Evaluation and Research (CBER) cited Moderna’s choice of a licensed standard-dose flu vaccine as the comparator in its Phase 3 trial, saying it “does not reflect the best-available standard of care.”
Nucala is the first and only monthly biologic in the EU evaluated in a wide COPD population with an eosinophilic phenotype
Inspection included drug device combinations covering our recent filing in nasal sprays domain
Subscribe To Our Newsletter & Stay Updated
